G. Werner

发表

Synthetic Peptides from a Hypothetical Receptor Binding Site: A Possible Approach to a Rhinovirus Vaccine?

G. Werner, J. McCray, 1989 .

A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export

J. Kjems, E. De Clercq, A. Vandamme, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Different rhinovirus serotypes neutralized by antipeptide antibodies

G. Werner, J. McCray, 1987, Nature.

Localization of the Human NA1 Alloantigen on Neutrophil Fc-γ-Receptors

G. Werner, P. Tetteroo, C. Engelfriet, 1986 .

Triggering the succinate receptor GPR91 on dendritic cells enhances immunity

T. Junt, A. Rot, Julian Kund, 2008, Nature Immunology.

Biologically active protease 3C of human rhinovirus 1A is expressed from a cloned cDNA segment in Escherichia coli.

B. Rosenwirth, G. Werner, J. McCray, 1991, Virology.

Inhibition of FcεRI-mediated activation of mast cells by 2,3,4-trihydropyrimidino[2,1-a]isoquinolines

P. Mayer, G. Werner, T. Baumruker, 1998 .

Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication

B. Wolff, A. Steinkasserer, G. Werner, 1995, Journal of virology.

G-protein-coupled bile acid receptor 1 (GPBAR1, TGR5) agonists reduce the production of proinflammatory cytokines and stabilize the alternative macrophage phenotype.

N. Schmiedeberg, J. Carballido, G. Werner, 2014, Journal of medicinal chemistry.

Protein expression in yeast; comparison of two expression strategies regarding protein maturation.

M. Schuster, A. Jungbauer, G. Werner, 2000, Journal of biotechnology.

Protein Expression Strategies for Identification of Novel Target Proteins

A Jungbauer, M. Schuster, A. Jungbauer, 2000, Journal of biomolecular screening.

Short cut of protein purification by integration of cell-disrupture and affinity extraction

A Jungbauer, M. Schuster, A. Jungbauer, 2000, Bioseparation.

Immunoreactivity of patient with colorectal cancer metastasis after immunisation with anti-idiotypes

H. Samonigg, H. Koprowski, A. Rot, 1990, The Lancet.

Deletions and insertions in adenovirus type 12 DNA after viral replication in Vero cells.

G. Werner, H. zur Hausen, 1978, Virology.

Immune response to tumor antigens in a patient with colorectal cancer after immunization with anti-idiotype antibody.

H. Samonigg, M. Wilders-Truschnig, A. Rot, 1992, Clinical immunology and immunopathology.

The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication

E. De Clercq, J. Anné, G. Werner, 1996, Journal of virology.

The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after binding.

I. De Clercq, A. Steinkasserer, W. James, 1996, Antiviral research.

Production and properties of site-specific antibodies to synthetic peptide antigens related to potential cell surface receptor sites for rhinovirus.

G. Werner, J. McCray, 1989, Methods in Enzymology.

Molecular cloning and sequence determination of the genomic regions encoding protease and genome-linked protein of three picornaviruses

B. Rosenwirth, J. Seifert, G. Werner, 1986, Journal of virology.

Localization of the Human NAt AIIoantigen on Neutropbll Fc-y-Receptors*

G. Werner, 1986 .